CBD Guides

CBD for restless legs: what the evidence says

By the Honest CBD Co team · 8th August 2026 · Updated 20th August 2026

Current evidence offers cautious support for CBD as a potential aid for restless legs syndrome (RLS), but the research is still early. Small open-label trials using combined THC/CBD formulations have reported improvements in symptom severity scores, and several registered trials are now underway testing high-CBD extracts specifically for idiopathic RLS. CBD alone has shown inconsistent results across studies. Before trying it, check with your GP if you take prescribed RLS medication, and buy from a seller who can tell you exactly what’s in the bottle.

Quick steps if you want to try CBD for RLS:

Speak to your GP first, especially if you take dopamine agonists, gabapentin, or pregabalin
Choose a full-spectrum or broad-spectrum product from a reputable UK seller
Start at a low dose in the evening and track your symptoms over four weeks
Check NHS guidance on RLS to confirm your diagnosis and understand standard treatment options
Review PubMed and clinicaltrials.gov for the latest registered trials

Key takeaways

CBD for RLS shows early promise in combined cannabinoid formulations, but current evidence is insufficient to recommend it as a standalone treatment, and a GP consultation is essential before starting if you take prescribed RLS medication.

What is restless legs syndrome and how does it affect daily life?
What does the research say about CBD for restless legs?
How might CBD help with restless legs symptoms?
Is CBD safe to use in the UK, and what are the risks?
How to try CBD for RLS safely: a practical framework
Conventional RLS treatments and where CBD fits in
What do active trials tell us about the future of CBD for RLS?
A frank note on CBD and RLS from our perspective
Our CBD products for UK adults with RLS
Sources

What is restless legs syndrome and how does it affect daily life?

Restless legs syndrome is a neurological condition marked by an irresistible urge to move the legs, usually alongside uncomfortable sensations described as crawling, tingling, or aching. The NHS defines the core diagnostic features as: symptoms that worsen at rest or in the evening, temporary relief with movement, and a pattern that disrupts sleep. Periodic limb movements during sleep often go with it.

Plenty of UK adults deal with RLS to some degree, and severe cases can badly disrupt sleep and daytime function. Secondary RLS can be triggered by iron deficiency, pregnancy, chronic kidney disease, or certain medications including antihistamines and some antidepressants.

What to tell your GP:

When symptoms started and how often they occur
Whether they are worse at rest, in the evening, or at night
Whether movement brings temporary relief
Any medications you currently take
Results of any iron or ferritin blood tests

Poor sleep from RLS compounds into fatigue, low mood, and reduced concentration. For people with moderate to severe symptoms, the impact on quality of life is comparable to other chronic conditions. That context matters when weighing any treatment, including CBD.

What does the research say about CBD for restless legs?

The honest answer is that the evidence is thin. Not absent, but thin. There are no completed placebo-controlled trials of CBD for RLS to point to, and most of the positive signals come from combined THC/CBD formulations rather than CBD alone.

One small open-label trial (n=18) reported that a 2.7 mg THC / 2.5 mg CBD formulation reduced RLS severity scores on the International Restless Legs Scale (IRLS) and reduced wake after sleep onset at one and three months. Encouraging, but an open-label design with 18 participants can’t establish cause and effect.

A systematic review of cannabinoid studies for sleep disorders identified 21 studies across multiple sleep conditions and concluded the evidence base is insufficient, calling for larger, standardised trials. A separate large decentralised trial (n≈1,793) found that low-dose CBD improved sleep disturbance but showed no superiority over 5 mg melatonin. A controlled crossover trial found that a 300 mg CBD-terpene formulation marginally increased slow-wave and REM sleep in selected subgroups, with no change in total sleep time.

“Many positive cannabis and RLS reports are unblinded, uncontrolled case series with a high risk of bias. Randomised, objective trials are needed before routine recommendation.” Narrative review, PMC

Pure CBD-only formulations have shown the most inconsistent results. Pilot studies suggest CBD may improve subjective wellbeing and, at selected doses, some objective sleep measures, but effects vary a lot between individuals. The clearest takeaway from the current literature is that formulation matters: combined cannabinoid products tend to outperform isolate CBD in the available data.

How might CBD help with restless legs symptoms?

CBD doesn’t work through a single pathway. It interacts with the endocannabinoid system, which plays a role in regulating pain perception, anxiety, and sleep. More specifically, CBD is thought to modulate glutamate signalling (which can reduce excitatory nerve activity), influence GABA pathways (which promote calm and sleep), and act on adenosine receptors involved in sleep pressure.

For RLS specifically, these mechanisms are plausible because the condition involves both sensory discomfort and sleep disruption. CBD’s anxiolytic properties may also reduce the distress that comes with symptoms, which can itself worsen the urge to move. If you want a deeper look at how CBD’s calming effects may indirectly support sleep, the best CBD for anxiety guide covers the anxiolytic evidence in more detail.

THC, by contrast, acts more directly on CB1 receptors and has a stronger sedative profile, which is why combined THC/CBD formulations have shown more consistent results in trials. CBD is non-intoxicating; THC is not. In the UK, THC is controlled under the Misuse of Drugs Act 1971, so any product legally sold as a food supplement can contain only trace amounts (no more than 1 mg per container).

Pro Tip: If a clinician is discussing a medicinal cannabis referral for refractory RLS, ask specifically about the CBD:THC ratio used in registered trials (such as the 5:1 ratio in NCT06863740). The ratio matters for both efficacy signals and side-effect profiles.

Is CBD safe to use in the UK, and what are the risks?

CBD is generally well tolerated at moderate doses. Common side effects include dry mouth, loose stools, drowsiness, and reduced appetite. Higher doses carry a greater risk of these effects and may affect liver enzyme levels with prolonged use.

The most clinically significant concern is drug interactions. CBD inhibits the CYP450 enzyme system, which metabolises many common medications including gabapentin, pregabalin, and some dopamine agonists used for RLS. This can alter how those drugs behave in your body. Always check with your GP or pharmacist before combining CBD with any prescribed RLS medication.

In the UK, hemp-derived CBD is legal as a food supplement provided it contains no more than 1 mg of THC per container. It isn’t a licensed medicine (with the exception of Epidyolex, which is prescription-only for epilepsy). The Food Standards Agency (FSA) regulates CBD novel food applications. Harvard Health guidance makes the same point we’d make: buy from a reputable seller who can tell you exactly what’s in their products, and avoid anything with unlabelled additives. For a full breakdown of common side effects, the CBD side effects guide is worth reading before you start.

Safety checklist:

Pregnant or breastfeeding: avoid CBD; evidence on foetal safety is insufficient
Elderly: start at the lowest possible dose; drowsiness increases fall risk
Driving: CBD can cause drowsiness, particularly at higher doses; do not drive until you know your response
Alcohol: combining CBD with alcohol may amplify sedative effects
Prescribed medications: check for CYP450 interactions with your pharmacist before starting

How to try CBD for RLS safely: a practical framework

Start only after speaking to your GP or pharmacist if you take prescription medication, or if you are pregnant or breastfeeding. The goal is a conservative, monitored trial with a clear review point.

Choose your form. A CBD oil allows flexible dosing and faster onset (15-45 minutes under the tongue). Capsules offer consistent, measured doses and are easier to track. Topicals applied to the legs may offer localised comfort but are unlikely to address the neurological side of RLS. For more on the muscle-related overlap, the CBD for muscle spasms article covers topical versus systemic options.
Start low. Begin with 10-20 mg CBD in the evening, 30-60 minutes before bed. The FSA advises healthy adults to keep CBD food-supplement intake to about 10 mg a day. It’s worth knowing that advice is deliberately precautionary, not a legal limit or a maximum dose: the FSA’s own guidance until autumn 2023 was 70 mg a day, clinical research has used doses in the hundreds of milligrams, and in our experience since 2018 most regular users settle somewhere between 25 mg and 100 mg or more a day. Our honest view is that the current figure is out of step with real-world use, but that’s our opinion, and starting low is still the sensible way in.
Track your symptoms. Use the IRLS questionnaire or a simple sleep diary to record symptom severity, sleep onset, and night-time waking. Note any side effects.
Increase slowly. If you tolerate the starting dose well after one week with no meaningful change, step up gradually until you find the level that works for you. Doses in published trials have ranged from 15 mg to 300 mg.
Set a review point. Reassess at four weeks. If there’s no improvement and no side effects, decide whether to continue, adjust, or stop.

Understanding the difference between product types matters here. Full-spectrum CBD contains the full range of cannabinoids from the hemp plant, including trace THC, and is associated with the “entourage effect,” where minor cannabinoids may amplify benefits. Broad-spectrum removes THC but keeps other cannabinoids. Isolate is pure CBD with no other plant compounds. For RLS, the available trial data leans towards full-spectrum or combined formulations rather than isolate. The full-spectrum meaning guide explains these distinctions clearly for UK buyers.

Conventional RLS treatments and where CBD fits in

Standard NHS treatment for RLS follows a stepped approach. For mild cases, lifestyle changes and addressing underlying causes (particularly iron deficiency) come first. For moderate to severe symptoms, clinicians now increasingly favour α2δ ligands such as gabapentin and pregabalin as first-line pharmacological options, partly because dopamine agonists carry a significant risk of augmentation, where symptoms worsen over time with continued use. Opioids are reserved for refractory cases under specialist supervision.

Common treatment options your GP may discuss:

Iron supplementation if ferritin is low (below 75 µg/L is a common threshold)
Gabapentin or pregabalin (α2δ ligands) for moderate to severe RLS
Pramipexole or ropinirole (dopamine agonists) with augmentation monitoring
Opioids (e.g. oxycodone) for severe, treatment-resistant cases under specialist care

CBD sits outside this pathway for now. It isn’t an NHS-recommended treatment for RLS, and no clinical guideline currently endorses it for this use. Where it may be reasonable is as an adjunct trial in people who have already discussed standard options with their GP, who aren’t on interacting medications, and who want to explore a natural supplement alongside lifestyle measures. It’s not a replacement for prescribed treatment.

See your GP promptly if your symptoms are worsening, if you suspect augmentation from a dopamine agonist, or if RLS is severely disrupting your sleep and daily function.

What do active trials tell us about the future of CBD for RLS?

Two registered trials are particularly relevant. The first, NCT06863740, is a randomised placebo-controlled trial testing a 5:1 CBD:THC oral formulation versus placebo in RLS, with primary endpoints including IRLS scores, the Pittsburgh Sleep Quality Index (PSQI), and actigraphy-based sleep measures. The second, NCT07224932, is testing BRC-002, a high-CBD botanical extract, specifically in idiopathic RLS, with a focus on safety, tolerability, and preliminary efficacy using the IRLS and sleep indices.

Trial	Design	Intervention	Key endpoints
NCT06863740	Randomised, placebo-controlled	5:1 CBD:THC oral formulation	IRLS, PSQI, actigraphy
NCT07224932	Registered RCT	BRC-002 high-CBD botanical extract	IRLS, sleep indices, tolerability

What better evidence would need to show:

Larger sample sizes (several hundred participants minimum)
Objective sleep measures alongside subjective scales
Dose-finding data to establish a therapeutic range
Longer follow-up periods (beyond three months)
Clear separation of CBD-only versus combined formulations

When these results are published, look for effect size (how large the improvement was, not just whether it was statistically significant) and whether the safety profile holds at the doses tested. A trial that shows a two-point IRLS improvement with significant side effects wouldn’t be a compelling case for routine use.

A frank note on CBD and RLS from our perspective

The most common question we get about CBD and restless legs is some version of: “Will it definitely help?” The truthful answer is that nobody knows yet, and anyone who tells you otherwise is overstating the evidence.

What the research does show is that cannabinoids interact with systems relevant to RLS: pain modulation, sleep regulation, and anxiety. The signals from combined THC/CBD trials are genuinely interesting. But interesting signals in small, open-label studies aren’t the same as proof, and the CBD-only data is particularly inconsistent.

What concerns us more than the evidence gap is the quality gap in the market. Plenty of people trying CBD for RLS are buying products with unclear cannabinoid content or unverified THC levels, from sellers who can’t say what’s actually in them. That’s a safety problem, not just a quality one, especially for anyone on prescribed medication where CYP450 interactions are a real clinical concern.

We started Honest CBD Co in 2018 because we believed people deserved properly made CBD at a fair price. We’re a husband-and-wife business in Bolton, we make everything in the UK in small batches, and we’re rated Excellent on Trustpilot with 732 reviews. If you’re considering a CBD trial for RLS, we’d rather you do it with a product from a seller you can trust than with one that just looks good on a shelf.

Consult your GP before starting, particularly if you take any prescribed RLS medication.

Our CBD products for UK adults with RLS

If you’ve spoken to your GP and want to try CBD as part of a monitored trial, we offer a straightforward starting point.

Our Full Spectrum CBD Oil comes in 10ml bottles at 10% (1000mg, £25.99) or 20% (2000mg, £37.99). Oils suit the start-low approach: you can begin at 10-20 mg in the evening and adjust drop by drop. Our Full Spectrum CBD Capsules suit those who prefer a fixed, consistent dose, in 40mg, 80mg, and 120mg strengths (15-packs from £19.99). The 40mg capsules are a sensible step once you’re past the starting-out stage, 80mg suits regular users, and 120mg is for experienced users who know their level. If you’d rather avoid THC entirely, our Pure CBD Isolate Oil is flavourless and THC-free, from £14.99 for 1000mg, though bear in mind the RLS trial data leans towards full-spectrum formulations. All our products are made in the UK in small batches and contain only legal trace levels of THC.

This isn’t medical advice. If you take prescribed medication for RLS, speak to your GP or pharmacist before starting any CBD product.

Sources

The sources below are cited in this article. Sharing them with your GP or specialist before starting a CBD trial is a sensible step.

This article provides general information only and is not a substitute for professional medical advice. Consult your GP or a qualified healthcare professional before making any changes to your RLS treatment.